Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Osband

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
American Journal of Diseases of Children (1960)|March 1, 1986
Study of thymic hormone therapy for histiocytosis XM E Osband
Hematology/Oncology Clinics of North America|March 1, 1987
Immunotherapy of histiocytosis-XM E Osband
Hematology/Oncology Clinics of North America|December 1, 1987
Histiocytosis X. Langerhans' cell histiocytosisM E Osband
Hematology/Oncology Clinics of North America|March 1, 1987
Histiocytosis-X: an overviewM E Osband, C Pochedly
Immunology Today|June 1, 1990
Problems in the investigational study and clinical use of cancer immunotherapyM E Osband, S Ross
Clinical Immunology and Immunopathology|June 1, 1994
Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cellsJ E Gold, M E Osband
Clinical Research|January 1, 1990
Biocare: biotechnology in the clinical practice of medicineM E Osband, G W Cashon
Pathology and Immunopathology Research|January 1, 1988
Autolymphocyte therapy: previous experience and future prospectsM E Osband, R J Krane
Hematology/Oncology Clinics of North America|March 1, 1987
Evaluating the role of therapy in histiocytosis-X. Clinical studies, staging, and scoringP T Lavin, M E Osband
Pediatrics|April 1, 1972
Lead paint exposure in migrant labor campsM E Osband, J R Tobin
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
American Journal of Diseases of Children (1960)|March 1, 1986
Study of thymic hormone therapy for histiocytosis XM E Osband
Hematology/Oncology Clinics of North America|March 1, 1987
Immunotherapy of histiocytosis-XM E Osband
Hematology/Oncology Clinics of North America|December 1, 1987
Histiocytosis X. Langerhans' cell histiocytosisM E Osband
Hematology/Oncology Clinics of North America|March 1, 1987
Histiocytosis-X: an overviewM E Osband, C Pochedly
Immunology Today|June 1, 1990
Problems in the investigational study and clinical use of cancer immunotherapyM E Osband, S Ross
Clinical Immunology and Immunopathology|June 1, 1994
Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cellsJ E Gold, M E Osband
Clinical Research|January 1, 1990
Biocare: biotechnology in the clinical practice of medicineM E Osband, G W Cashon
Pathology and Immunopathology Research|January 1, 1988
Autolymphocyte therapy: previous experience and future prospectsM E Osband, R J Krane
Hematology/Oncology Clinics of North America|March 1, 1987
Evaluating the role of therapy in histiocytosis-X. Clinical studies, staging, and scoringP T Lavin, M E Osband
Pediatrics|April 1, 1972
Lead paint exposure in migrant labor campsM E Osband, J R Tobin
Pageof 4